Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

NCT03983226 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

167

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ovarian Cancer Recurrent
Fallopian Tube Cancer
Primary Peritoneal Carcinoma

Interventions

PROCEDURE: Surgery
DRUG: carboplatin/taxane, carboplatin/gemcitabine, cisplatin/gemcitabine, liposome doxorubicin/carboplatin...
DRUG: Niraparib

Sponsor

Shanghai Gynecologic Oncology Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]